AAAAAA
Results: 1-25/36
Authors:
Rappl, G
Abken, H
Hasselmann, DO
Tilgen, W
Ugurel, S
Reinhold, U
Citation: G. Rappl et al., The CD7(-) subset of CD4(+) memory T cells is prone to accelerated apoptosis that is prevented by interleukin-15 (IL-15), CELL DEAT D, 8(4), 2001, pp. 395-402
Authors:
Ugurel, S
Rappl, G
Tilgen, W
Reinhold, U
Citation: S. Ugurel et al., Increased soluble CD95 (sFas/CD95) serum level correlates with poor prognosis in melanoma patients, CLIN CANC R, 7(5), 2001, pp. 1282-1286
Authors:
Hasselmann, DO
Rappl, G
Rossler, M
Ugurel, S
Tilgen, W
Reinhold, U
Citation: Do. Hasselmann et al., Detection of tumor-associated circulating mRNA in serum, plasma and blood cells from patients with disseminated malignant melanoma, ONCOL REP, 8(1), 2001, pp. 115-118
Authors:
Gross, T
Wagner, A
Ugurel, S
Tilgen, W
Reinhold, U
Citation: T. Gross et al., Identification of TIA-1+and granzyme B plus cytotoxic T cells in lichen sclerosus et atrophicus, DERMATOLOGY, 202(3), 2001, pp. 198-202
Authors:
Seiter, S
Ugurel, S
Tilgen, W
Reinhold, U
Citation: S. Seiter et al., High-dose pulse corticosteroid therapy in the treatment of severe alopeciaareata, DERMATOLOGY, 202(3), 2001, pp. 230-234
Authors:
Reinhold, U
Berkin, C
Bosserhoff, AK
Deutschmann, A
Garbe, C
Glaser, R
Hein, R
Krahn, G
Peter, RU
Rappl, G
Schittek, B
Seiter, S
Ugurel, S
Volkenandt, M
Tilgen, W
Citation: U. Reinhold et al., Interlaboratory evaluation of a new reverse transcriptase polymerase chainreaction-based enzyme-linked immunosorbent assay for the detection of circulating melanoma cells: A multicenter study of the dermatologic cooperativeoncology group, J CL ONCOL, 19(6), 2001, pp. 1723-1727
Authors:
Ugurel, S
Rappl, G
Tilgen, W
Reinhold, U
Citation: S. Ugurel et al., Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival, J CL ONCOL, 19(2), 2001, pp. 577-583
Authors:
Rappl, G
Muche, JM
Abken, H
Sterry, W
Tilgen, W
Ugurel, S
Reinhold, U
Citation: G. Rappl et al., CD4(+)CD7(-) T cells compose the dominant T-cell clone in the peripheral blood of patients with Sezary syndrome, J AM ACAD D, 44(3), 2001, pp. 456-461
Authors:
Gantenbein, C
Seite, S
Weik, R
Reinhold, U
Ruprecht, KW
Tilgen, W
Citation: C. Gantenbein et al., Ocular manifestation of progressive essential telangiectases, J FR OPHTAL, 24(1), 2001, pp. 45-48
Authors:
Koch, P
Reinhold, U
Tilgen, W
Citation: P. Koch et al., Olmsted syndrome, ANN DER VEN, 128(4), 2001, pp. 538-540
Authors:
Seiter, S
Stassar, M
Rappl, G
Reinhold, U
Tilgen, W
Zoller, M
Citation: S. Seiter et al., Upregulation of C4.4 A expression during progression of melanoma, J INVES DER, 116(2), 2001, pp. 344-347
Authors:
Rappl, G
Kapsokefalou, A
Heuser, C
Rossler, M
Ugurel, S
Tilgen, W
Reinhold, U
Abken, H
Citation: G. Rappl et al., Dermal fibroblasts sustain proliferation of activated T cells via membrane-bound interleukin-15 upon long-term stimulation with tumor necrosis factor-alpha, J INVES DER, 116(1), 2001, pp. 102-109
Authors:
Tilgen, W
Citation: W. Tilgen, On the 65th birthday of Detlef Petzoldt, HAUTARZT, 52(4), 2001, pp. 354-355
Authors:
Hasselmann, DO
Rappl, G
Tilgen, W
Reinhold, U
Citation: Do. Hasselmann et al., Extracellular tyrosinase mRNA within apoptotic bodies is protected from degradation in human serum, CLIN CHEM, 47(8), 2001, pp. 1488-1489
Authors:
Ugurel, S
Rebmann, V
Ferrone, S
Tilgen, W
Grosse-Wilde, H
Reinhold, U
Citation: S. Ugurel et al., Soluble human leukocyte antigen-G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy, CANCER, 92(2), 2001, pp. 369-376
Authors:
Hauschild, A
Garbe, C
Stolz, W
Ellwanger, U
Seiter, S
Dummer, R
Ugurel, S
Sebastian, G
Nashan, D
Linse, R
Achtelik, W
Mohr, P
Kaufmann, R
Fey, M
Ulrich, J
Tilgen, W
Citation: A. Hauschild et al., Dacarbazine and interferon alpha with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG), BR J CANC, 84(8), 2001, pp. 1036-1042
Authors:
Reinhold, U
Ugurel, S
Tilgen, W
Kadiata, MM
Olivares, E
Nadi, AB
Malaisse, WJ
Citation: U. Reinhold et al., Antitumoral action of 2-deoxy-D-glucose tetraacetate in human melanoma cells, ONCOL REP, 7(5), 2000, pp. 1093-1097
Authors:
Pfohler, C
Ugurel, S
Seiter, S
Wagner, A
Tilgen, W
Reinhold, U
Citation: C. Pfohler et al., Interferon-alpha-associated development of bullous lesions in mycosis fungoides, DERMATOLOGY, 200(1), 2000, pp. 51-53
Authors:
Middleton, MR
Grob, JJ
Aaronson, N
Fierlbeck, G
Tilgen, W
Seiter, S
Gore, M
Aamdal, S
Cebon, J
Coates, A
Dreno, B
Henz, M
Schadendorf, D
Kapp, A
Weiss, J
Fraass, U
Statkevich, P
Muller, M
Thatcher, N
Citation: Mr. Middleton et al., Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma, J CL ONCOL, 18(1), 2000, pp. 158-166
Authors:
Rass, K
Gutwein, P
Muller, SM
Friedrich, M
Meineke, V
Welter, C
Tilgen, W
Reichrath, J
Citation: K. Rass et al., Immunohistochemical analysis of DNA mismatch repair enzyme hMSH-2 in normal human skin and basal cell carcinomas, HISTOCHEM J, 32(2), 2000, pp. 93-97
Authors:
Reichrath, J
Classen, UG
Meineke, V
DeLuca, H
Tilgen, W
Kerber, A
Holick, MF
Citation: J. Reichrath et al., Immunoreactivity of six monoclonal antibodies directed against 1,25-dihydroxyvitamin-D-3 receptors in human skin, HISTOCHEM J, 32(10), 2000, pp. 625-629
Authors:
Tilgen, W
Citation: W. Tilgen, Increasing incidence of basal cell epitheliomas and spinocellular carcinomas in Saarland, HAUTARZT, 51(12), 2000, pp. 956-956
Authors:
Seiter, S
Ugurel, S
Tilgen, W
Reinhold, U
Citation: S. Seiter et al., Use of high-dose methylprednisolone pulse therapy in patients with progressive and stable vitiligo, INT J DERM, 39(8), 2000, pp. 624-627
Authors:
Liu, L
Abken, H
Pfohler, C
Rappl, G
Tilgen, W
Reinhold, U
Citation: L. Liu et al., Accumulation of CD4(+)CD7(-) T cells in inflammatory skin lesions: evidence for preferential adhesion to vascular endothelial cells, CLIN EXP IM, 121(1), 2000, pp. 94-99
Authors:
Ugurel, S
Pfoiiler, C
Tilgen, W
Reinhold, U
Citation: S. Ugurel et al., S100-beta serum protein - a new marker in the diagnosis and monitoring of Langerhans cell histiocytosis?, BR J DERM, 143(1), 2000, pp. 201-202